Your browser is no longer supported. Please, upgrade your browser.
Settings
PAVM [NASD]
PAVmed Inc.
Index- P/E- EPS (ttm)-0.55 Insider Own12.35% Shs Outstand82.23M Perf Week-26.30%
Market Cap557.78M Forward P/E- EPS next Y-0.45 Insider Trans0.00% Shs Float75.55M Perf Month-20.00%
Income-35.40M PEG- EPS next Q-0.13 Inst Own25.00% Short Float6.87% Perf Quarter15.15%
Sales- P/S- EPS this Y-31.50% Inst Trans-0.12% Short Ratio2.48 Perf Half Y35.11%
Book/sh0.49 P/B12.41 EPS next Y18.20% ROA-109.80% Target Price8.75 Perf Year205.53%
Cash/sh0.47 P/C12.91 EPS next 5Y- ROE-196.40% 52W Range1.63 - 9.70 Perf YTD186.79%
Dividend- P/FCF- EPS past 5Y-35.80% ROI- 52W High-37.32% Beta0.14
Dividend %- Quick Ratio8.70 Sales past 5Y- Gross Margin- 52W Low273.01% ATR0.60
Employees25 Current Ratio8.70 Sales Q/Q- Oper. Margin- RSI (14)32.66 Volatility9.80% 7.69%
OptionableYes Debt/Eq0.00 EPS Q/Q-11.30% Profit Margin- Rel Volume2.51 Prev Close6.58
ShortableYes LT Debt/Eq0.00 EarningsAug 12 AMC Payout- Avg Volume2.10M Price6.08
Recom2.00 SMA20-25.94% SMA50-20.41% SMA20013.99% Volume5,255,318 Change-7.60%
Mar-30-21Initiated Cantor Fitzgerald Overweight $8
Nov-05-20Initiated Ascendiant Capital Markets Buy $5
Jun-28-18Initiated Maxim Group Buy $5
Oct-13-21 10:15PM  
09:28PM  
Oct-07-21 11:41AM  
09:30AM  
Sep-30-21 10:34AM  
Sep-23-21 01:35PM  
12:39PM  
09:30AM  
Sep-21-21 09:30AM  
Sep-07-21 10:04AM  
Aug-13-21 12:16PM  
Aug-12-21 04:14PM  
Aug-10-21 09:30AM  
Aug-05-21 09:30AM  
Aug-03-21 09:30AM  
Aug-02-21 12:31PM  
Jul-28-21 04:42PM  
09:30AM  
Jul-22-21 09:30AM  
Jun-14-21 09:30AM  
05:06AM  
Jun-10-21 09:30AM  
Jun-02-21 09:30AM  
May-26-21 09:30AM  
May-25-21 09:30AM  
May-24-21 09:30AM  
May-17-21 04:00PM  
02:45PM  
May-13-21 09:30AM  
May-06-21 09:30AM  
May-03-21 09:30AM  
Apr-29-21 09:30AM  
Apr-27-21 09:30AM  
Apr-15-21 09:30AM  
Apr-08-21 09:30AM  
Mar-10-21 09:30AM  
Mar-03-21 09:30AM  
Mar-01-21 09:30AM  
Feb-25-21 12:37PM  
Feb-23-21 09:00AM  
07:25AM  
Feb-22-21 04:13PM  
08:18AM  
Feb-18-21 09:30AM  
Feb-16-21 09:30AM  
Feb-11-21 08:30AM  
Feb-09-21 09:30AM  
Jan-08-21 10:53AM  
Jan-06-21 09:29AM  
Dec-22-20 12:04PM  
Dec-18-20 09:29AM  
Dec-16-20 02:53AM  
Dec-11-20 09:29AM  
Nov-30-20 09:15PM  
Nov-17-20 04:00PM  
02:45PM  
Nov-02-20 09:30AM  
Oct-06-20 07:30AM  
Sep-08-20 09:30AM  
Aug-27-20 09:30AM  
Aug-18-20 04:14PM  
Aug-06-20 09:27AM  
Aug-05-20 09:00AM  
Jul-28-20 09:30AM  
Jul-14-20 11:11PM  
Jul-13-20 09:30AM  
Jul-07-20 12:15PM  
Jun-17-20 09:30AM  
Jun-15-20 09:30AM  
07:30AM  
Jun-11-20 09:30AM  
Jun-03-20 09:30AM  
May-27-20 05:08PM  
May-21-20 04:00PM  
02:30PM  
May-11-20 09:30AM  
Apr-22-20 10:12AM  
Apr-21-20 09:30AM  
Apr-20-20 07:05PM  
Apr-09-20 04:44PM  
02:30PM  
Apr-02-20 09:30AM  
Mar-31-20 09:30AM  
Mar-24-20 09:30AM  
Mar-09-20 09:30AM  
Mar-02-20 09:30AM  
Feb-20-20 09:30AM  
Feb-18-20 09:30AM  
Feb-12-20 09:18AM  
Feb-11-20 09:30AM  
Jan-14-20 07:55AM  
Jan-13-20 09:30AM  
Dec-19-19 09:30AM  
Dec-16-19 06:16PM  
Dec-13-19 09:30AM  
Nov-29-19 10:37PM  
Nov-21-19 04:00PM  
Nov-14-19 09:30AM  
Nov-07-19 09:30AM  
Nov-06-19 09:30AM  
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE). Its product pipeline also comprises EsoGuard, a molecular diagnostic esophageal DNA test; EsoCure, an esophageal ablation device to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; NextFlo, a disposable infusion platform technology; PortIO, an implantable intraosseous vascular access device; and DisappEAR, a resorbable pediatric ear tube, as well as NextCath and Caldus. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is based in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Aklog LishanChairman and CEOMar 18Buy4.317,50032,3241,105,913Mar 19 01:07 PM
SIROVICH MATTHEW10% OwnerNov 25Sale1.9633,20365,0481,027,744Nov 27 03:07 PM
SIROVICH MATTHEW10% OwnerNov 24Sale2.0053,036105,8761,060,947Nov 27 03:07 PM
SIROVICH MATTHEW10% OwnerNov 19Sale1.8375,211137,4181,113,983Nov 20 01:01 PM
SIROVICH MATTHEW10% OwnerNov 18Sale1.7824,78944,1641,189,194Nov 20 01:01 PM